X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Strides Pharma Science Ltd.
BSE CODE: 532531   |   NSE CODE: STAR   |   ISIN CODE : INE939A01011   |   21-Nov-2024 Hrs IST
BSE NSE
Rs. 1503.10
110.6 ( 7.94% )
 
Prev Close ( Rs.)
1392.50
Open ( Rs.)
1432.95
 
High ( Rs.)
1528.35
Low ( Rs.)
1391.30
 
Volume
25023
Week Avg.Volume
63787
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 1503.65
111.45 ( 8.01% )
 
Prev Close ( Rs.)
1392.20
Open ( Rs.)
1408.80
 
High ( Rs.)
1529.00
Low ( Rs.)
1392.30
 
Volume
618632
Week Avg.Volume
344256
 
52 WK High-Low Range(Rs.)
482
1675
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)7.13  0.52  20.07  8.72  13.43  
   CEPS(Rs)16.34  10.89  31.69  19.80  23.95  
   DPS(Rs)2.50  1.50  0.00  2.50  14.00  
   Book NAV/Share(Rs)387.16  380.46  379.13  361.65  352.04  
   Tax Rate(%)5.93  107.23  -737.77  29.91  11.85  
Margin Ratios          
   Core EBITDA Margin(%)11.49  4.46  3.87  8.57  12.08  
   EBIT Margin(%)11.03  3.99  4.84  9.53  12.02  
   Pre Tax Margin(%)3.23  -3.49  1.09  6.01  8.06  
   PAT Margin (%)3.04  0.25  9.10  4.21  7.11  
   Cash Profit Margin (%)6.97  5.30  14.38  9.56  12.68  
Performance Ratios          
   ROA(%)1.16  0.09  3.43  1.61  2.63  
   ROE(%)1.87  0.14  5.42  2.45  3.76  
   ROCE(%)4.77  1.56  2.18  4.35  5.03  
   Asset Turnover(x)0.38  0.34  0.38  0.38  0.37  
   Sales/Fixed Asset(x)1.79  1.60  1.85  1.92  2.03  
   Working Capital/Sales(x)5.12  5.63  14.78  12.12  -27.77  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.56  0.62  0.54  0.52  0.49  
   Receivable days238.70  256.27  195.32  145.14  133.56  
   Inventory Days81.44  98.79  110.86  113.17  100.98  
   Payable days189.28  220.46  228.47  226.09  204.46  
Valuation Parameters          
   PER(x)109.82  551.91  17.27  96.80  24.02  
   PCE(x)47.90  26.29  10.94  42.65  13.47  
   Price/Book(x)2.02  0.75  0.91  2.34  0.92  
   Yield(%)0.32  0.52  0.00  0.30  4.34  
   EV/Net Sales(x)4.03  2.07  2.19  4.51  2.15  
   EV/Core EBITDA(x)26.48  21.08  21.70  30.33  12.21  
   EV/EBIT(x)36.52  52.05  45.35  47.35  17.86  
   EV/CE(x)1.68  0.80  0.81  1.63  0.79  
   M Cap / Sales3.34  1.39  1.57  4.08  1.71  
Growth Ratio          
   Net Sales Growth(%)16.11  -6.29  6.54  9.79  10.05  
   Core EBITDA Growth(%)79.45  -8.78  -27.58  -7.13  17.30  
   EBIT Growth(%)221.35  -22.80  -45.90  -12.94  21.64  
   PAT Growth(%)1298.78  -97.40  130.30  -34.95  5.13  
   EPS Growth(%)1274.48  -97.42  130.02  -35.03  5.11  
Financial Stability Ratios          
   Total Debt/Equity(x)0.45  0.39  0.37  0.27  0.27  
   Current Ratio(x)1.21  1.18  1.07  1.10  0.96  
   Quick Ratio(x)0.98  0.91  0.79  0.66  0.64  
   Interest Cover(x)1.41  0.53  1.29  2.71  3.04  
   Total Debt/Mcap(x)0.22  0.52  0.40  0.12  0.30